AbCellera Biologics Inc. (ABCL)
NASDAQ·Healthcare·Biotechnology
$6.12
+4.89%
Mkt Cap $1.65B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$7.50
Range $7.00 – $8.00
Implied Upside
+22.6%
Consensus $7.50 vs current $6.12
NASDAQ·Healthcare·Biotechnology
$6.12
+4.89%
Mkt Cap $1.65B
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$7.50
Range $7.00 – $8.00
+22.6%
Consensus $7.50 vs current $6.12